Adelaide Research & Scholarship: Search

Search

Search:
for

Current filters:

Start a new search

Add filters:

Results/Page | Sort items by In order Authors/record

Results 11-20 of 25 (Search time: 0.004 seconds).

Item hits:

Preview	Issue Date	Title	Author(s)
	2015	A multicenter randomized trial of continuous versus intermittent β-lactam infusion in severe sepsis	Dulhunty, J.; Roberts, J.; Davis, J.; Webb, S.; Bellomo, R.; Gomersall, C.; Shirwadkar, C.; Eastwood, G.; Myburgh, J.; Paterson, D.; Starr, T.; Paul, S.; Lipman, J.; Peck, L.; Young, H.; Boschert, C.; Fletcher, J.; Smith, J.; Nand, K.; Sara, T.; et al.
	2015	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response	Biernacka, J.; Sangkuhl, K.; Jenkins, G.; Whaley, R.; Barman, P.; Batzler, A.; Altman, R.; Arolt, V.; Brockmöller, J.; Chen, C.; Domschke, K.; Hall-Flavin, D.; Hong, C.; Illi, A.; Ji, Y.; Kampman, O.; Kinoshita, T.; Leinonen, E.; Liou, Y.; Mushiroda, T.; et al.
	2021	HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders	Le Clerc, S.; Lombardi, L.; Baune, B.T.; Amare, A.T.; Schubert, K.O.; Hou, L.; Clark, S.R.; Papiol, S.; Cearns, M.; Heilbronner, U.; Degenhardt, F.; Tekola-Ayele, F.; Hsu, Y.-H.; Shekhtman, T.; Adli, M.; Akula, N.; Akiyama, K.; Ardau, R.; Arias, B.; Aubry, J.-M.; et al.
	2021	Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients with Difficult to Cure Characteristics	Papaluca, T.; Roberts, S.K.; Strasser, S.I.; Stuart, K.A.; Farrell, G.; Macquillan, G.; Dore, G.J.; Wade, A.J.; George, J.; Hazeldine, S.; O'Beirne, J.; Wigg, A.; Fisher, L.; McGarity, B.; Sawhney, R.; Sinclair, M.; Thomas, J.; Valiozis, I.; Weltman, M.; Wilson, M.; et al.
	2013	Salvage second hematopoietic cell transplantation in myeloma	Michaelis, L.; Saad, A.; Zhong, X.; Le-Rademacher, J.; Freytes, C.; Marks, D.; Lazarus, H.; Bird, J.; Holmberg, L.; Kamble, R.; Kumar, S.; Lill, M.; Meehan, K.; Saber, W.; Schriber, J.; Tay, J.; Vogl, D.; Wirk, B.; Savani, B.; Gale, R.; et al.
	2021	The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study	Hodgson, C.L.; Higgins, A.M.; Bailey, M.J.; Mather, A.M.; Beach, L.; Bellomo, R.; Bissett, B.; Boden, I.J.; Bradley, S.; Burrell, A.; Cooper, D.J.; Fulcher, B.J.; Haines, K.J.; Hopkins, J.; Jones, A.Y.M.; Lane, S.; Lawrence, D.; van der Lee, L.; Liacos, J.; Linke, N.J.; et al.
	2015	Crohn's disease management after intestinal resection: a randomised trial	De Cruz, P.; Kamm, M.; Hamilton, A.; Ritchie, K.; Krejany, E.; Gorelik, A.; Liew, D.; Prideaux, L.; Lawrance, I.; Andrews, J.; Bampton, P.; Gibson, P.; Sparrow, M.; Leong, R.; Florin, T.; Gearry, R.; Radford-Smith, G.; Macrae, F.; Debinski, H.; Selby, W.; et al.
	2012	Death adder envenoming causes neurotoxicity not reversed by antivenom - Australian snakebite project (ASP-16)	Johnston, C.; O'Leary, M.; Brown, S.; Currie, B.; Halkidis, L.; Whitaker, R.; Close, B.; Isbister, G.; Nagree, Y.; Ker, F.; Greene, S.; Taylor, M.; Macrokanis, C.; Wilke, G.; Coulson, A.; Barnes, C.; Bonni, R.; Whitake, R.; Halkidis, L.; Isbiste, G.; et al.; de Silva, J.
	2015	A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma	Pal, S.; Azad, A.; Bhatia, S.; Drabkin, H.; Costello, B.; Sarantopoulos, J.; Kanesvaran, R.; Lauer, R.; Starodub, A.; Hauke, R.; Sweeney, C.; Hahn, N.; Sonpavde, G.; Richey, S.; Breen, T.; Kremmidiotis, G.; Leske, A.; Doolin, E.; Bibby, D.; Simpson, J.; et al.
	2015	TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets	Yeung, D.; Osborn, M.; White, D.; Branford, S.; Braley, J.; Herschtal, A.; Kornhauser, M.; Issa, S.; Hiwase, D.; Hertzberg, M.; Schwarer, A.; Filshie, R.; Arthur, C.; Kwan, Y.; Trotman, J.; Forsyth, C.; Taper, J.; Ross, D.; Beresford, J.; Tam, C.; et al.